MRCP Part 1 → Clinical sciences
Clinical sciences accounts for roughly 12.5% of the MRCP Part 1 blueprint. This bank has 248 items tagged to it.
Around 12.5% of the paper, per MRCP(UK) examination blueprints and regulations. That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
Minutes after eating a takeaway containing peanuts, a 25-year-old man develops widespread urticaria, swelling of his lips and tongue, wheeze and stridor, and becomes hypotensive with a systolic of 80 mmHg. He is anxious and short of breath. What is the most likely diagnosis?
The point: Anaphylaxis is a severe, life-threatening, generalised hypersensitivity reaction, most often an IgE-mediated type I reaction in which allergen cross-links mast-cell and basophil IgE, triggering massive release of histamine and other mediators. It develops rapidly, usually within minutes of exposure to a trigger such as foods (nuts, shellfish), drugs (antibiotics, especially penicillins, and NSAIDs), insect stings or latex. The diagnosis is clinical: a sudden onset with rapidly progressing Airway, Breathing or Circulation problems (stridor and swelling, wheeze and hypoxia, or hypotension and collapse), usually with skin and mucosal changes such as urticaria and angioedema, though skin changes can be absent. The single most important treatment is intramuscular adrenaline into the anterolateral thigh (0.5 mg of 1 in 1000 in an adult), given immediately and repeated after 5 minutes if there is no improvement; delay in giving adrenaline is the commonest avoidable factor in fatal anaphylaxis. Alongside this the patient is positioned (lying flat with legs raised if hypotensive, sitting up if breathing is the problem), given high-flow oxygen and intravenous fluids for hypotension, and the trigger removed. Antihistamines and steroids are no longer first-line and, if used at all, are secondary to adrenaline. A serum mast-cell tryptase, taken during and after the reaction, supports the diagnosis retrospectively. After recovery, patients are observed for a biphasic reaction, prescribed adrenaline auto-injectors with training, and referred to an allergy clinic to identify the trigger. Anaphylaxis illustrates the core immunology of type I hypersensitivity that MRCP tests in clinical sciences.
Source: Resuscitation Council UK — emergency treatment of anaphylaxis guideline Resuscitation Council UK · tier 2, specialty society or college
Minutes after eating a takeaway containing peanuts, a 25-year-old man develops widespread urticaria, swelling of his lips and tongue, wheeze and stridor, and becomes hypotensive with a systolic of 80 mmHg. He is anxious and short of breath. What is the most appropriate investigation?
The point: Anaphylaxis is a severe, life-threatening, generalised hypersensitivity reaction, most often an IgE-mediated type I reaction in which allergen cross-links mast-cell and basophil IgE, triggering massive release of histamine and other mediators. It develops rapidly, usually within minutes of exposure to a trigger such as foods (nuts, shellfish), drugs (antibiotics, especially penicillins, and NSAIDs), insect stings or latex. The diagnosis is clinical: a sudden onset with rapidly progressing Airway, Breathing or Circulation problems (stridor and swelling, wheeze and hypoxia, or hypotension and collapse), usually with skin and mucosal changes such as urticaria and angioedema, though skin changes can be absent. The single most important treatment is intramuscular adrenaline into the anterolateral thigh (0.5 mg of 1 in 1000 in an adult), given immediately and repeated after 5 minutes if there is no improvement; delay in giving adrenaline is the commonest avoidable factor in fatal anaphylaxis. Alongside this the patient is positioned (lying flat with legs raised if hypotensive, sitting up if breathing is the problem), given high-flow oxygen and intravenous fluids for hypotension, and the trigger removed. Antihistamines and steroids are no longer first-line and, if used at all, are secondary to adrenaline. A serum mast-cell tryptase, taken during and after the reaction, supports the diagnosis retrospectively. After recovery, patients are observed for a biphasic reaction, prescribed adrenaline auto-injectors with training, and referred to an allergy clinic to identify the trigger. Anaphylaxis illustrates the core immunology of type I hypersensitivity that MRCP tests in clinical sciences.
Source: Resuscitation Council UK — emergency treatment of anaphylaxis guideline Resuscitation Council UK · tier 2, specialty society or college
Minutes after eating a takeaway containing peanuts, a 25-year-old man develops widespread urticaria, swelling of his lips and tongue, wheeze and stridor, and becomes hypotensive with a systolic of 80 mmHg. He is anxious and short of breath. What is the most appropriate management?
The point: Anaphylaxis is a severe, life-threatening, generalised hypersensitivity reaction, most often an IgE-mediated type I reaction in which allergen cross-links mast-cell and basophil IgE, triggering massive release of histamine and other mediators. It develops rapidly, usually within minutes of exposure to a trigger such as foods (nuts, shellfish), drugs (antibiotics, especially penicillins, and NSAIDs), insect stings or latex. The diagnosis is clinical: a sudden onset with rapidly progressing Airway, Breathing or Circulation problems (stridor and swelling, wheeze and hypoxia, or hypotension and collapse), usually with skin and mucosal changes such as urticaria and angioedema, though skin changes can be absent. The single most important treatment is intramuscular adrenaline into the anterolateral thigh (0.5 mg of 1 in 1000 in an adult), given immediately and repeated after 5 minutes if there is no improvement; delay in giving adrenaline is the commonest avoidable factor in fatal anaphylaxis. Alongside this the patient is positioned (lying flat with legs raised if hypotensive, sitting up if breathing is the problem), given high-flow oxygen and intravenous fluids for hypotension, and the trigger removed. Antihistamines and steroids are no longer first-line and, if used at all, are secondary to adrenaline. A serum mast-cell tryptase, taken during and after the reaction, supports the diagnosis retrospectively. After recovery, patients are observed for a biphasic reaction, prescribed adrenaline auto-injectors with training, and referred to an allergy clinic to identify the trigger. Anaphylaxis illustrates the core immunology of type I hypersensitivity that MRCP tests in clinical sciences.
Source: Resuscitation Council UK — emergency treatment of anaphylaxis guideline Resuscitation Council UK · tier 2, specialty society or college
Clinical pharmacology and therapeutics · Cardiology · Respiratory medicine · Gastroenterology and hepatology · Neurology · Endocrinology, diabetes and metabolic medicine · Renal medicine · Infectious diseases · Rheumatology · Haematology · Psychiatry · Dermatology · Geriatric medicine · Oncology · Medical ophthalmology · Palliative medicine and end of life care